We are live on ! Find out more
GSK icon

GSK
GSK

763 hedge funds and large institutions have $9.69B invested in GSK in 2017 Q4 according to their latest regulatory filings, with 135 funds opening new positions, 168 increasing their positions, 348 reducing their positions, and 109 closing their positions.

New
Increased
Maintained
Reduced
Closed

24% more first-time investments, than exits

New positions opened: 135 | Existing positions closed: 109

3% more funds holding

Funds holding: 741 → 763 (+22)

7% more call options, than puts

Call options by funds: $107M | Put options by funds: $99.7M

0.46% more ownership

Funds ownership: 3.95% → 4.41% (+0.46%)

2% less capital invested

Capital invested by funds: $9.84B → $9.69B (-$148M)

10% less funds holding in top 10

Funds holding in top 10: 10 → 9 (-1)

52% less repeat investments, than reductions

Existing positions increased: 168 | Existing positions reduced: 348

Holders
763
Holders Change
+22
Holders Change %
+2.97%
% of All Funds
17.31%
Holding in Top 10
9
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-10%
% of All Funds
0.2%
New
135
Increased
168
Reduced
348
Closed
109
Calls
$107M
Puts
$99.7M
Net Calls
+$7.16M
Net Calls Change
-$43.6M

Top Buyers

Rank Fund Capital Flow
1
Dodge & Cox
Dodge & Cox
California
+$1.08B
2
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
+$624M
3
Two Sigma Advisers
Two Sigma Advisers
New York
+$66.9M
4
CCM
Camber Capital Management
Massachusetts
+$55.4M
5
Millennium Management
Millennium Management
New York
+$48.7M

Top Sellers

Rank Fund Capital Flow
1
Wells Fargo
Wells Fargo
California
-$197M
2
Bank of America
Bank of America
North Carolina
-$125M
3
HCM
Hamlin Capital Management
New York
-$72M
4
MHI
Miller Howard Investments
New York
-$56.4M
5
Morgan Stanley
Morgan Stanley
New York
-$38.2M
Name Holding Trade Value Shares
Change 		Change in
Stake
HIM
751
Hillsdale Investment Management
Ontario, Canada
$3K -$1.48K -32 -31%
BC
752
Barnett & Company
Tennessee
$3K – – –
DBT
753
Dubuque Bank & Trust
Iowa
$3K – – –
LWM
754
Lenox Wealth Management
Ohio
$3K +$2.82K +61 New
AIM
755
Arcadia Investment Management
Michigan
$2K -$12.8K -278 -86%
AIP
756
Ameritas Investment Partners
Nebraska
$2K – – –
LWA
757
Lowe Wealth Advisors
Maryland
$2K – – –
Parallax Volatility Advisers
758
Parallax Volatility Advisers
California
$2K +$2.08K +45 New
YWP
759
YorkBridge Wealth Partners
New York
$1K -$5.91K -128 -85%
CIM
760
Contravisory Investment Management
Massachusetts
$1K +$647 +14 New
WC
761
Whitnell & Co
Illinois
$1K +$1.25K +27 New
Walleye Trading
762
Walleye Trading
New York
$170 -$18.8K -407 -10%
PCG
763
Private Capital Group
Connecticut
$151 +$64.4K +1,394 New
HCM
764
Hamlin Capital Management
New York
– -$72M -1,418,398 Closed
O
765
OppenheimerFunds
New York
– -$35.7M -703,466 Closed
Point72 Asset Management
766
Point72 Asset Management
Connecticut
– -$24.5M -483,535 Closed
OCM
767
Osterweis Capital Management
California
– -$21.1M -416,032 Closed
NC
768
Nexthera Capital
New York
– -$14.5M -286,442 Closed
GHA
769
GW Henssler & Associates
Georgia
– -$8.54M -168,274 Closed
NFA
770
Nationwide Fund Advisors
Ohio
– -$8.01M -157,854 Closed
NAM
771
NorthCoast Asset Management
Connecticut
– -$4.87M -95,860 Closed
DAS
772
Dynamic Advisor Solutions
Arizona
– -$3.87M -76,226 Closed
ARTA
773
A.R.T. Advisors
New York
– -$3.25M -64,080 Closed
SSWM
774
Smith Salley Wealth Management
North Carolina
– -$3.05M -60,096 Closed
GCC
775
Guardian Capital (Canada)
Ontario, Canada
– -$2.75M -54,200 Closed
29 30
31
32 33

GSK Hedge Fund Activity: Q4 2017 in Review

763 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in GSK (GSK) for Q4 2017, worth a combined $9.69B — down 1.5% from $9.84B a quarter earlier.

Buyers outnumbered sellers: 135 funds opened new GSK positions and 109 closed out — a net gain of 26 holders — while 168 added to existing stakes and 348 trimmed.

The largest buyer was Dodge & Cox, adding an estimated $1.08B. The largest seller was Wells Fargo, cutting an estimated $197M.

  • 763 institutional investors held GSK (GSK) as of Q4 2017, up from 741 in Q3 2017.
  • Funds reported $9.69B of GSK stock for Q4 2017, down 1.5% quarter-over-quarter.
  • 135 funds opened new GSK positions in Q4 2017 and 109 closed out, a net change of +26 holders.
  • The largest GSK buyer in Q4 2017 was Dodge & Cox, an estimated $1.08B added.
  • The largest GSK seller in Q4 2017 was Wells Fargo, an estimated $197M sold.

Based on aggregated 13F filings for Q4 2017.